DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Cuker A, Coles AJ, Sullivan H. et al.
A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Blood 2011;
118: 6299-6305
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.